Sandstone Diagnostics provides an integrated wellness technology that empowers consumers to measure, monitor, and improve their health.
Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 6, 2019 | Series A | $2.50M | 1 | — | — | Detail |
Jan 16, 2018 | Series A | $5.80M | 1 | — | — | Detail |
Jun 25, 2014 | Angel | $1.80M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
LabCorp | — | Series A |
DPW Holdings | — | Series A |
Treasure Valley Angel Fund | — | Angel |